{"name":"Entasis Therapeutics","slug":"entasis-therapeutics","ticker":"","exchange":"","domain":"entasis.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPWVFZYkM2ZVNhb18tQkdkNVd5ZnZ2dG53emxGUnhsRTVWTU9KZ0U3Nl9DZGtzeFU0Y3FGT0oydVNKVmlOcGRiU2FmVnpEWWZfT1ZFZFo5cUt3SHVKd0w0Q0JObklJUDg4NnVwVF8xZ2tKRnRkTldYeEVhbGFvdkQ1azQybDB0MUpzdkxlc3g3dktsUVJfWHp3ZFdCWk9hbjVTOGNDeg?oc=5","date":"2026-04-02","type":"pipeline","source":"Investor's Business Daily","summary":"Analysts See This Pharma Stock Surging 60%; Eyes Fresh Entry - Investor's Business Daily","headline":"Analysts See This Pharma Stock Surging 60%; Eyes Fresh Entry - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNWU5KSWRVTnNMRkVYdDlEcXFyQlpCaU9jTXVnYU55WlloS2tRMDFrZ3VfdnFVTVFEeHNSM1BsaVplMVlza2pycmZ1TUZIYnJWWHFvRWh3SlhONHpabXRWN1RTekRYM1FyOEhTdVc4YlBZYnFDT3Vhd0djUDRScHNPWGRsdGhBbXh6b3JmY0JSRm9KUWo2U0U5R195V2dqQXN4TmZUX21hemwzMl9JcTh1U0Rzc1QyQQ?oc=5","date":"2025-12-15","type":"pipeline","source":"Pharmaceutical Technology","summary":"First gonorrhoea antibiotics in decades herald new era of treatment - Pharmaceutical Technology","headline":"First gonorrhoea antibiotics in decades herald new era of treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPMTNKVWpPVllxT0taVjFiZzdkOWVJaDNodFhxaENpdkRCQlVWdVNZdW9PZmlsMHdnLTczd2hjbXlkZ3hQZ3QwOFNMb2lZRTRBNVBUVDVFVW1JeWdFLXdhN29PWW12UVZqR1RNWTlQNzJzbnIzOXdoVURuS29IZWY2ck5tX3Izajh4RDJqOUtIcktkOUF5ajVEUURB?oc=5","date":"2025-12-13","type":"regulatory","source":"The Pharma Letter","summary":"FDA approves two oral therapies to treat gonorrhea - The Pharma Letter","headline":"FDA approves two oral therapies to treat gonorrhea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOUThoUUFMd0RBalphNkFEVVZOLVp5emlKYmw1eVVEWjZ2eW9LamFNSWhVdWJZWDBCel9oeTRfbGt3cG5NdnctSFFUaGk0azNSZGVIY2Y1bVl4U2dXOTBiU1lOUk54YTVqOUJucmhQSVRFcGh3LUtUUE92YWQ5bGhCVUMyRTQ4X0lrZGp6bHVVXzNLU25HU0NDaG5XMGk2RG9xUWNVbnZqWWpORXJkYUxYcjFlanA5QXF2?oc=5","date":"2023-05-24","type":"regulatory","source":"Fierce Pharma","summary":"Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro - Fierce Pharma","headline":"Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPeGstamZ2TVp3UU1EcEFsN3o2U2tVUjdKNDBSZTBrbE5KOEd4WDBucW1WVUlXUHBkUmFQSnMxX19YZjduOEU1QnZtVUVmYjA0SXI0QWI2ZFMyUE1TRWY5YWF1R1I1QXV1OElRejNlMm9CQldFcVU3RVJwdUh3VzJ0YkllUW1mYmNTdXFUbC1SelRIMk9VNHFXVGhWUG53S083aVVpUmV6bHE4THJ4VVFkbA?oc=5","date":"2022-07-11","type":"pipeline","source":"businesswire.com","summary":"Innoviva Completes Acquisition of Entasis Therapeutics - businesswire.com","headline":"Innoviva Completes Acquisition of Entasis Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOSy1iZFU4Vng4bGlqZWVkOFUxTDhBMERJRnkwc2lGN2czNlg0ODNOdTlVVnU5R0xSeUphSGFCOUdQajRVTjZKZG1aWWNjbFQ3cndFbG1UYjRraFdBQy1wOGdVVk03M2hWbUc5V3dkbm14SV84dWlqWWQwZlpPV2tKVHVWMk56aHk0MnFEc0VvcWszcFJlUHJPX1JEUENVVk5u?oc=5","date":"2022-07-11","type":"deal","source":"BioPharma Dive","summary":"Healthcare asset manager Innoviva buys another biotech at a bargain price - BioPharma Dive","headline":"Healthcare asset manager Innoviva buys another biotech at a bargain price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQcTRjUDhIVUZXVDNYa2treVowNENTMW54RTVodjRsNFZ3Zl9zb0UtMHlKWWF0WUsyRkJJTV95T0FmSFpReDkxZDlsNml4TnI1SzV3WlJtNjhNY1NPdm1YRGNDUjFrU2hiLVJ3UE9MSWo1YU50WFZxVXpqMVIwV0tTaUpycTdsRkttNG45VmdpX1dfLUFISTZxSHhydjVnS1Yzdk5rUEZZMA?oc=5","date":"2022-05-24","type":"deal","source":"The Business Journals","summary":"AstraZeneca spinout, based in Waltham, acquired at 60% premium - The Business Journals","headline":"AstraZeneca spinout, based in Waltham, acquired at 60% premium","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNeV9wMi15NGR4UW0tOGZzOGZHLXpDMkRNU3liX1dkaHRiRmtJV3pzdVVMRW1KYUt6RlBMb2dhSml3QnNWd29TbVFwU0JDYU96VHV3RnlkNndMYmh0R09jMW11ZmxoUzlGd1NwNDFtTW0wNzZ1UklTWmNUeWhsQmRZSg?oc=5","date":"2022-05-24","type":"deal","source":"Pharmaceutical Technology","summary":"Innoviva enters agreement to acquire biopharma firm Entasis - Pharmaceutical Technology","headline":"Innoviva enters agreement to acquire biopharma firm Entasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPa0pqV1FpSVVtMUgtZW44N3E1dzV2ZlhlcVpULUtvNDVvS1ZBTzdsWW1FWXRKYm44SmpDSDlQSWFIZ2J6WnYtOGp1TDhSVWRMazdrVzB6QXFsa285ZngyYUpGYnJGanp2bWFJRW5MajJJOUdkU3paUTFJaVFJMkoxOWpHeW9nMUl2TmRtblZKTzBITU95dTFOWEpGUGxOei1weVJWdXJyT2lacWJIYXlaLUdjb0NSdw?oc=5","date":"2022-05-23","type":"regulatory","source":"Fierce Biotech","summary":"Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spinout preps FDA filing - Fierce Biotech","headline":"Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spinout preps FDA filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPZ0lWZzZQMWFUTE16OUFtUzJ0NHVLYjJpU2djSXRDdTNDUWdtSFNKUGRkVFdpX3RSU2FZbUU5VldFS0NLeVlhVkpNUDhXRFFWck9kRER6X3pEU3g1VTRhQm5SSy1UWGNtOUxNUXl3MmpBTEtzcUJiZW1kd0plQlgyQVREdlZyWHBac1JNRDdEQzRtbzlFOFktekNyODVsR3RoTEx4YkIzRFRoOTFpazRmTWlB?oc=5","date":"2022-05-23","type":"deal","source":"GlobeNewswire","summary":"Innoviva to Acquire Entasis Therapeutics - GlobeNewswire","headline":"Innoviva to Acquire Entasis Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxORlE0dzFtalhHemZVY0tJLUkweV84S1dFUUk5QVZ5YnZtd0o3N0lKalllbExiUFFDS05lVEJuck5YY0dsenFuUWVhTGVCRkJRcUd1LXBrN2hYS0J6bTdoTjZFSkowMjdYSjNnN1ZmX0ZzZjdTUmk3cVY3X1RrVXc0V0hVMThUbjR4YWozcFdjRk5XQQ?oc=5","date":"2021-10-19","type":"trial","source":"CIDRAP","summary":"New drug for Acinetobacter infections shows promise in phase 3 trial - CIDRAP","headline":"New drug for Acinetobacter infections shows promise in phase 3 trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNblJ5MHA5MnZrQjFOZWZGeGg1WllaczN3ZTAwUEJERlFwMWV5QVY5MTJKaU1OdDZtUUxGU0c2Q0JnZlBualh0VE5vMWVzSkhCRjA3WVlMUDJhYnRLRFhVd0pqa3kzeWJSdEF4U21jWFlNZlAtTnpiYzZrVVJnTk1raw?oc=5","date":"2016-04-05","type":"pipeline","source":"pharmaphorum","summary":"AstraZeneca spin-off Entasis raises $50m to develop new antibiotics - pharmaphorum","headline":"AstraZeneca spin-off Entasis raises $50m to develop new antibiotics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}